Pancreatic cancer treatment at Sourasky Medical Center (Ichilov)

Pancreatic cancer treatment is available at Sourasky Medical Center (Ichilov) in Tel Aviv, Israel. An initial consultation may cost around $850, with comprehensive genomic testing at approximately $4,840 and targeted therapy provided on an outpatient basis. The clinic offers a complete care pathway directed by Professor Ido Wolf, who leads Israel's National Council for Malignant Diseases.

Expert-Led Diagnostic Evaluation

The clinic provides a thorough diagnostic plan. It begins with an oncology consultation. Subsequent steps include detailed imaging and molecular profiling. The available diagnostics are designed to create a precise treatment strategy.

• Oncologist consultation: Evaluation with a senior specialist.
• PET-FDG CT scan: Advanced imaging to locate and stage the cancer.
• Laboratory blood tests: Includes CBC, chemistry, and specific tumor markers (CEA, CA19-9).
• Genomic profiling: Foundation One CDx NGS and MMR testing to identify targetable mutations.
• Pre-treatment assessments: Echocardiography and DPYD enzyme genotyping to plan safe therapy.

Personalized Treatment Strategies

Treatment is tailored based on the diagnostic results. Professor Wolf's team uses the latest genomic data to guide decisions. Options aim to maximize effectiveness while minimizing hospital stays.

The Sourasky Medical Center provides several systemic therapy options:

• Tailored Systemic Chemotherapy: Customized drug regimens administered in a day-hospital setting.
• Targeted Molecular Therapy: Uses drugs that attack specific genetic mutations found in the cancer cells.
• Clinical Trial Access: Opportunity to receive experimental therapies through international collaborative trials.

Clinic Environment and Support

Sourasky Medical Center is a JCI-accredited facility. It is Israel's largest multidisciplinary medical center. The hospital treats approximately 40,000 cancer patients each year. Its medical tourism department assists international patients with coordination, airport transfers, and interpreter services.

Professor Ido Wolf directs the Oncology Division with over 32 years of experience. He completed a research fellowship at UCLA and has published over 100 scientific papers. His leadership extends to chairing Israel's National Council for Malignant Diseases. This expertise guides every patient's personalized care plan at Ichilov.